Be sure to check out the newest paper from our group, Drug Delivery Strategies and Nanozyme Technologies to Overcome Limitations for Targeting Oxidative Stress in Osteoarthritis, an invited review published in Pharmaceuticals. In this review, Jessica discusses the current state of nanozyme technologies for use as a therapeutic treatment for osteoarthritis. At this time, there are only 11 different nanozyme therapies being utilized in OA research even though they have been widely evaluated in other healthcare fields. You can check out the review here: Drug Delivery Strategies and Nanozyme Technologies to Overcome Limitations for Targeting Oxidative Stress in Osteoarthritis
